• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HNRNPC通过调节N-甲基腺苷修饰的WDR77 mRNA的稳定性以及转化生长因子-β(TGF-β)和SMAD3的表达来促进瘢痕疙瘩进展。

HNRNPC Promotes Keloid Progression by Modulating the Stability of N-Methyladenosine-Modified WDR77 mRNA and Expression of TGF-β and SMAD3.

作者信息

Zhan Yuanyuan, Zeng Ning, Yu Jing, Wu Yiping, Zhu Keyu, Yang Zihui, Guo Xingjun, Zhang Qi, Liu Zeming

机构信息

Department of Plastic and Cosmetic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

J Invest Dermatol. 2025 Jun 6. doi: 10.1016/j.jid.2025.01.038.

DOI:10.1016/j.jid.2025.01.038
PMID:40484365
Abstract

Keloid is a cutaneous fibrotic disorder distinguished by uncontrolled dermal fibroblast proliferation and accumulation of collagen. N-methyladenosine (MA) modification is the most prevalent epitranscriptomic modification of eukaryotic mRNAs. MA modification participates in a variety of biological processes of cells by influencing the stability, translation efficiency, splicing, and transport of mRNAs. Recently, mA modification in keloids has garnered interest but is not fully understood. In this study, we discovered that keloids were in hyper-mA-modified status, and HNRNPC was overexpressed in keloid tissues and keloid fibroblasts. The knockdown of HNRNPC inhibited the migration and proliferation of keloid fibroblasts. Through RNA immunoprecipitation PCR and luciferase experiments, WDR77 was identified as an mA-dependent direct downstream target of HNRNPC. Furthermore, HNRNPC promoted the expression of WDR77 by increasing WDR77 stability, elevating the expression of TGF-β and SMAD3. In keloid xenograft nude mice, HNRNPC small interfering RNAs significantly limited keloid development with reduced WDR77 and TGF-β expression. Thus, our study revealed that HNRNPC regulated the pathological functions of keloid fibroblasts through the mA methylation of WDR77 mRNA and that the inhibition of HNRNPC limited keloid progression in vivo. Our results decipher an mA-related mechanism and potential therapeutic strategy for combating keloids.

摘要

瘢痕疙瘩是一种皮肤纤维化疾病,其特征在于真皮成纤维细胞不受控制的增殖和胶原蛋白的积累。N-甲基腺苷(m⁶A)修饰是真核生物mRNA中最普遍的表观转录组修饰。m⁶A修饰通过影响mRNA的稳定性、翻译效率、剪接和转运参与细胞的多种生物学过程。最近,瘢痕疙瘩中的m⁶A修饰引起了人们的关注,但尚未完全了解。在本研究中,我们发现瘢痕疙瘩处于高m⁶A修饰状态,且HNRNPC在瘢痕疙瘩组织和瘢痕疙瘩成纤维细胞中过表达。敲低HNRNPC可抑制瘢痕疙瘩成纤维细胞的迁移和增殖。通过RNA免疫沉淀PCR和荧光素酶实验,WDR77被鉴定为HNRNPC的m⁶A依赖性直接下游靶点。此外,HNRNPC通过增加WDR77稳定性、提高TGF-β和SMAD3的表达来促进WDR77的表达。在瘢痕疙瘩异种移植裸鼠中,HNRNPC小干扰RNA显著限制了瘢痕疙瘩的发展,同时WDR77和TGF-β表达降低。因此,我们的研究表明,HNRNPC通过WDR77 mRNA的m⁶A甲基化调节瘢痕疙瘩成纤维细胞的病理功能,并且抑制HNRNPC可在体内限制瘢痕疙瘩的进展。我们的结果揭示了一种与m⁶A相关的机制以及对抗瘢痕疙瘩的潜在治疗策略。

相似文献

1
HNRNPC Promotes Keloid Progression by Modulating the Stability of N-Methyladenosine-Modified WDR77 mRNA and Expression of TGF-β and SMAD3.HNRNPC通过调节N-甲基腺苷修饰的WDR77 mRNA的稳定性以及转化生长因子-β(TGF-β)和SMAD3的表达来促进瘢痕疙瘩进展。
J Invest Dermatol. 2025 Jun 6. doi: 10.1016/j.jid.2025.01.038.
2
Mechanism of the N6-methyladenosine reader heterogeneous nuclear ribonucleoprotein C facilitating immune escape in thyroid cancer by stabilizing programmed death ligand 1.N6-甲基腺苷阅读器异质核糖核蛋白C通过稳定程序性死亡配体1促进甲状腺癌免疫逃逸的机制
Cytotechnology. 2025 Jun;77(3):96. doi: 10.1007/s10616-025-00755-1. Epub 2025 May 6.
3
Silicone gel sheeting for treating keloid scars.硅凝胶片治疗瘢痕疙瘩。
Cochrane Database Syst Rev. 2023 Jan 3;1(1):CD013878. doi: 10.1002/14651858.CD013878.pub2.
4
New Anti-Fibrotic Strategies for Keloids: Insights From Single-Cell Multi-Omics.瘢痕疙瘩的新型抗纤维化策略:单细胞多组学研究启示
Cell Prolif. 2025 Jun;58(6):e13818. doi: 10.1111/cpr.13818. Epub 2025 Feb 4.
5
Secreted phosphoprotein 1 promotes the activation of keloid fibroblasts via the CD44/TGF-β1/Smad pathway.分泌型磷蛋白1通过CD44/TGF-β1/Smad途径促进瘢痕疙瘩成纤维细胞的活化。
Exp Cell Res. 2025 Jul 15;450(2):114658. doi: 10.1016/j.yexcr.2025.114658. Epub 2025 Jun 24.
6
Hyodeoxycholic acid ameliorates cholestatic liver fibrosis by facilitating mA-regulated expression of a novel anti-fibrotic target ETV4.猪去氧胆酸通过促进由 mA 调控的新型抗纤维化靶点 ETV4 的表达来改善胆汁淤积性肝纤维化。
J Hepatol. 2025 Feb 4. doi: 10.1016/j.jhep.2025.01.020.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.